Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancers|July 24, 2021
Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient ManagementKatharina Kessel, Christof Bernemann, Martin Bögemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2020
Radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysisRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
Theranostics|August 15, 2019
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617Katharina Kessel, Robert Seifert, Michael Schäfers, et al.
Cancers|August 7, 2021
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future PerspectivesKonstantin Egon Seifert, Robert Seifert, Katharina Kessel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted TherapyRobert Seifert, Katharina Kessel, Martin Boegemann, et al.
Theranostics|July 21, 2020
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyRobert Seifert, Konstantin Seitzer, Ken Herrmann, et al.
Theranostics|July 21, 2020
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Annals of Nuclear Medicine|December 2, 2021
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imagingKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Theranostics|August 10, 2021
Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapyRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2018
Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki DiseaseGiulia Armaroli, Emely Verweyen, Carolin Pretzer, et al.
Pageof 2